Artificial intelligence vs experts reading blood clotting tests
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study tests whether a computer program (artificial intelligence) can interpret ROTEM blood clotting tests as well as expert doctors. If you've had a ROTEM test, your data may be used to help improve how these tests are read.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have had a ROTEM test (a blood test that checks how well your blood clots) done with a ROTEM Sigma device as part of your regular medical care.
- The test must have been done in a situation where doctors needed to check your clotting, such as during surgery, after a trauma, or in critical illness.
- The full results of the test (both graphs and numbers) must be available.
- The test must not have used the HEPTEM channel (which is used to detect heparin effects).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a bedside machine (TEG 6s) can measure blood clotting in children during planned surgery. It may help doctors get faster, more accurate information about clotting during the operation.
This trial is testing if a special blood test called ROTEM can help doctors predict the risk of bleeding after high-risk procedures in people with cirrhosis. It aims to improve safety and guide treatment decisions.
This trial tests whether using a slightly different target on a blood-clotting test (ROTEM) can reduce the need for blood transfusions in people with liver disease who need a procedure. If you have cirrhosis or ACLF with severe clotting problems, this study may help your doctors decide how much blood product to give you before the procedure.
This study is testing whether an artificial intelligence system can help doctors interpret routine blood test results more accurately. If you've had a recent blood test at a participating hospital, your results may be used to help improve this technology.
This study is testing a special blood test called ROTEM to see how well it can predict bleeding problems in ICU patients with sepsis or severe trauma. It may help doctors give the right treatment faster.
This trial uses an artificial intelligence (AI) system to read CT scan images of the lungs and predict outcomes after a pulmonary embolism (a blood clot in the lung). It may help doctors identify who is at higher risk, so treatment decisions can be faster and more accurate.
Hear when a new Coagulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.